The facility is expected to produce 500 million vaccine doses annually
Audio By Carbonatix
Kenya has signed a deal with US biotechnology company, Moderna Inc, to build a vaccine manufacturing facility in the country.
The facility if expected to produce up to 500 million doses of vaccines annually.
The deal has been hailed as one that will help solve vaccine access in the current coronavirus pandemic and in future pandemics.
Moderna anticipates to invest more than $500m (£380m) in the facility.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
DISCLAIMER: The Views, Comments, Opinions, Contributions and Statements made by Readers and Contributors on this platform do not necessarily represent the views or policy of Multimedia Group Limited.
Latest Stories
-
ECG procurement is where politicians ‘milk’ the company – Ben Boakye
33 minutes -
IPPs’ contractual arrangements partly to blame for energy sector problems – TUC’s Dr Otoo
44 minutes -
Like Benzema & as good as Haaland – Alonso on Joao Pedro
48 minutes -
Check out 41 countries Ghanaians can visit without a visa on ordinary passports
58 minutes -
I disrupted pre-season travel plans to prepare players – Arteta
1 hour -
Richarlison’s move to Vasco da Gama falls through
1 hour -
Dictator meme shows lack of human awareness – Mbappe
1 hour -
2030 World Cup: Moroccan official told to stop making 2030 final promise
1 hour -
Mourinho compares Mbappe and Vini Jr to fruit trees after boos
2 hours -
Lewis Hall signs new contract with Newcastle until 2031
2 hours -
Signed instead of Rashford, Gordon is proving worth at Barca
2 hours -
2026 BECE automatic placement rate hits 87.3%, highest since 2021 — CSSPS data
2 hours -
Ghanaian youngster Zayan Omar joins Spanish side Málaga
2 hours -
New Man City signings desperate to win – Dias
2 hours -
Morocco rejects Spain blame game, warns against using kingdom as political pawn
2 hours